Hemangioendothelioma Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Sirolimus in the Treatment for Infantile Hepatic Hemangioendothelioma(IEEH)
Condition: Hemangioendothelioma of Liver Interventions: Drug: Sirolimus Oral Product; Drug: propranolol Sponsor: Shanghai Children's Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 29, 2020 Category: Research Source Type: clinical trials
Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma
Conditions: Hemangioma; Kaposiform Hemangioendothelioma Interventions: Drug: Sirolimus(0.8mg/m2); Drug: Sirolimus(0.7mg/m2) Sponsor: Children's Hospital of Fudan University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 4, 2019 Category: Research Source Type: clinical trials
